Department of Psychiatry, Nara Medical University, 840 Shijo-Cho Kashihara, Nara, 634-8521, Japan.
Department of Emergency and Critical Care Medicine, Nara Medical University, 840 Shijo-Cho Kashihara, Nara, 634-8521, Japan.
BMC Psychiatry. 2020 Jun 16;20(1):311. doi: 10.1186/s12888-020-02723-9.
Most suicide attempters suffer from psychiatric disorders, which are often comorbid with personality disorders. The effects of intervention on patients who have attempted suicide with comorbid Axis I and II diagnoses have not been fully elucidated. We evaluated whether assertive case management can reduce the repetition of suicidal behaviours in patients who had attempted suicide with comorbid Axis I and II diagnoses.
This study was a secondary analysis of a randomised controlled trial investigating whether assertive case management could reduce the repetition of suicide attempts, compared with enhanced usual care. Subjects were divided into those who had comorbid Axis I and II diagnoses (Axis I + II group), and those who had an Axis I diagnosis without Axis II comorbidity (Axis I group). Outcome measures were compared between patients receiving a case management intervention and patients receiving enhanced usual care, as allocated. The primary outcome measure was the incidence proportion of the first episode of recurrent suicidal behaviour at 6 months after randomisation. We calculated risk ratios (RR) with 95% confidence intervals (CI) at 6 months and 12 months after randomisation of patients in the Axis I and Axis I + II groups.
Of 914 enrolled patients, 120 (13.1%) were in the Axis I + II group, and 794 (86.9%) were in the Axis I group. Assertive case management was significantly effective for the Axis I group on the primary outcome at 6 months (risk ratio [RR] 0.51, 95% confidence intervals [CI] 0.31 to 0.84). The RR of the Axis I + II group was 0.44 (95% CI 0.14 to 1.40).
Assertive case management not only had an effect on patients who had attempted suicide with only Axis I disorders but may also have a similar effect on patients with comorbid Axis I and II disorders.
大多数自杀未遂者患有精神疾病,这些疾病通常与人格障碍并存。针对同时存在轴 I 和轴 II 诊断的自杀未遂患者进行干预的效果尚未完全阐明。我们评估了果断的个案管理是否可以减少同时存在轴 I 和轴 II 诊断的自杀未遂患者重复自杀行为。
这是一项随机对照试验的二次分析,旨在评估果断的个案管理是否可以减少自杀未遂的复发,与增强的常规护理相比。将研究对象分为同时存在轴 I 和轴 II 诊断的患者(轴 I + II 组)和仅存在轴 I 诊断而无轴 II 合并症的患者(轴 I 组)。比较了接受个案管理干预的患者和按分配接受增强常规护理的患者之间的结局指标。主要结局指标是随机分组后 6 个月内首次复发自杀行为的发生率。我们计算了轴 I 和轴 I + II 组患者在随机分组后 6 个月和 12 个月时的复发率(RR)及其 95%置信区间(CI)。
在纳入的 914 名患者中,120 名(13.1%)为轴 I + II 组,794 名(86.9%)为轴 I 组。在主要结局上,果断的个案管理在 6 个月时对轴 I 组的效果显著(RR 0.51,95% CI 0.31 至 0.84)。轴 I + II 组的 RR 为 0.44(95% CI 0.14 至 1.40)。
果断的个案管理不仅对仅存在轴 I 障碍的自杀未遂患者有效,而且对同时存在轴 I 和轴 II 障碍的患者也可能有效。